What are alternatives to propranolol (beta-blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternatives to Propranolol (Beta-Blocker)

There are several effective alternatives to propranolol, with metoprolol succinate extended-release being the most appropriate sustained-release alternative according to current guidelines. 1

Beta-Blocker Alternatives

Cardioselective Beta-Blockers

  • Metoprolol

    • Metoprolol succinate (extended-release): 50-200 mg once daily 2
    • Metoprolol tartrate: 100-200 mg twice daily 2
    • Benefits: Cardioselective (beta-1 selective), preferred in patients with bronchospastic airway disease requiring a beta-blocker 2
  • Atenolol: 25-100 mg twice daily 2

    • Benefits: Cardioselective, once or twice daily dosing
  • Bisoprolol: 2.5-10 mg once daily 2

    • Benefits: Highly cardioselective, once-daily dosing, preferred in heart failure patients 1
  • Betaxolol: 5-20 mg once daily 2

    • Benefits: Cardioselective, once-daily dosing
  • Nebivolol: 5-40 mg once daily 2

    • Benefits: Cardioselective with vasodilatory properties through nitric oxide induction 2

Non-Cardioselective Beta-Blockers

  • Nadolol: 40-120 mg once daily 2
    • Benefits: Long half-life allowing once-daily dosing
    • Caution: Avoid in patients with reactive airways disease 2

Combined Alpha and Beta-Blockers

  • Carvedilol: 12.5-50 mg twice daily 2

    • Benefits: Preferred in patients with heart failure with reduced ejection fraction (HFrEF) 2
    • Carvedilol phosphate: 20-80 mg once daily 2
  • Labetalol: 200-800 mg twice daily 2

    • Benefits: Combined alpha and beta blockade, useful in hypertensive emergencies

Algorithm for Selecting a Propranolol Alternative

  1. Assess patient's comorbidities:

    • Respiratory disease: Choose a cardioselective agent (metoprolol, bisoprolol, atenolol) 2
    • Heart failure: Prefer carvedilol, metoprolol succinate, or bisoprolol 2
    • Coronary artery disease: Any beta-blocker is appropriate, with preference for those studied post-MI (metoprolol, propranolol, atenolol) 2
  2. Consider dosing convenience:

    • Once-daily preference: Metoprolol succinate ER, bisoprolol, nadolol
    • Twice-daily requirement: Metoprolol tartrate, carvedilol
  3. Special populations:

    • Elderly patients: Consider starting with lower doses, particularly with metoprolol 1
    • Women: May require lower doses of metoprolol than men (approximately 50% reduction) 1
    • Hepatic dysfunction: Dose adjustment needed for metoprolol 1

Important Precautions

  • Avoid abrupt cessation of any beta-blocker to prevent rebound hypertension or tachycardia 2

  • Contraindications for all beta-blockers:

    • Marked first-degree AV block (PR interval >0.24s)
    • Second or third-degree AV block without pacemaker
    • Severe bradycardia
    • Cardiogenic shock
    • Decompensated heart failure 2, 1
  • Initiation protocol:

    • Start with low doses and gradually titrate upward
    • For metoprolol and most beta-blockers, begin with the lowest effective dose and increase at 1-2 week intervals 2
    • Monitor heart rate, blood pressure, and symptoms during titration 1

Conversion from Propranolol

When converting from propranolol to another beta-blocker, consider these approximate equivalencies:

  • Propranolol 80 mg ≈ Metoprolol 100 mg ≈ Atenolol 50 mg ≈ Bisoprolol 5 mg ≈ Carvedilol 25 mg 1

Beta-blockers remain essential medications for cardiovascular conditions, and selecting the right alternative to propranolol should be based on patient-specific factors including comorbidities, dosing convenience, and specific indications.

References

Guideline

Beta Blocker Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.